ACAD vs PHAR
ACADIA Pharmaceuticals Inc. · Pharming Group N.V.
Relative return (rebased to 100)
Key stats
| Metric | ACAD | PHAR |
|---|---|---|
| Price | $28.45 | $10.85 |
| Market Cap | $4.87B | $7.61B |
| P/E | 12.46 | 2670.37 |
| P/B | 3.90 | 27.47 |
| P/S | 4.55 | 20.24 |
| ROE | 31.3% | 1.0% |
| Net Margin | 36.5% | 0.8% |
| Gross Margin | 63.9% | 87.9% |
| Revenue Growth | 11.9% | 26.6% |
| Dividend Yield | — | — |
| EPS | $2.28 | $0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.